In this episode of the OIS Podcast, host Dr. Firas Rahhal, along with expert panelists, Dr. Robert Bhisitkul, Dr. Alan Franklin and Dr. Paul Karpecki at OIS XIII, takes listeners on a deep dive into the transformative landscape of oral therapies in retina

ViaLase, a clinical stage medical technology company located in Aliso Viejo, CA is focused on disrupting the conventional glaucoma treatment paradigm with the introduction of a truly noninvasive image-guided femtosecond laser treatment that enhances glauc

Opthea, an Australian based biopharmaceutical company is dedicated to transforming retinal disease treatments and elevating patients' vision and quality of life. Join Firas Rahal, MD, in a captivating episode as he engages with Opthea's Founder

Harrow isnt a household name (yet), but eye care professionals have trusted its products for over a decade.The Nashville-based company produces Dexycu, an intraocular steroid; Iopidine for intraocular pressure control; and most recently, five Novartis pr

Endogena Therapeutics has developed a novel approach to regenerative medicine thats not only scientifically compelling, but practical.Endogenas technology unlocks the bodys own stem cells for controlled tissue repair by small molecules. Its products us

You can see and feel a buzz within the company right now, said Andrew Stewart, President, Global Pharmaceuticals and International Consumer, at Bausch + Lomb.Bausch + Lombs current momentum stems not only from new leadership, but also from recent colla

OIS Podcast host Carey Powers caught up with four ophthalmology execs and one principal investigator to talk about some of the most exciting developments in retina R&D.Her guests include:Houman David Hemmati, MD, PhD, Cofounder and Chief Medical Offic

OIS Podcast host Carey Powers speaks with four CEOs from leading retina-focus companies to talk about all things innovation. Her guests include: Kerrie Brady, BPharm, President and CEO of OcuTerra Rich Small, CEO of NeuroTech Pharmaceuticals Kester

At-home OCT enables daily monitoring of patients with neovasular age-related macular degeneration (AMD) and other patients that need a lot of follow-ups.With host Carey Powers, Dr. Anat Loewenstein dives into at-home OCT innovation, application, and adopt

Keith Valentine is the first and only visually impaired head of a national sight loss organization in the UK.As the President and CEO of Vision Foundation, Londons leading sight loss charity, Valentine guides an organization that provides services for bl